Search

Your search keyword '"Miller, David P."' showing total 56 results

Search Constraints

Start Over You searched for: Author "Miller, David P." Remove constraint Author: "Miller, David P." Publisher wiley-blackwell Remove constraint Publisher: wiley-blackwell
56 results on '"Miller, David P."'

Search Results

1. Putting participants and study partners FIRST when clinical trials end early.

2. Diagnostic criteria for apathy in neurocognitive disorders.

4. Mapping of validated apathy scales onto the apathy diagnostic criteria for neurocognitive disorders.

5. Agitation in Alzheimer's disease: Novel outcome measures reflecting the International Psychogeriatric Association (IPA) agitation criteria.

6. Successful molecular detection studies require clear communication among diverse research partners.

7. Long‐term effects of grazing management and buffer strips on phosphorus runoff from pastures fertilized with poultry litter.

8. Are There Differences in Screening MMSE Interview Durations Between Subjects Who Maintain Severity and Subjects Who Drop Below Screening Inclusionary MMSE Thresholds at Baseline? An Exploratory Analysis.

9. Do Subjects Not Meeting Screening Inclusion Criteria at Baseline Differ in Screening Performance in Diagnostic Tests in Early Dementia Clinical Trails?

10. Phosphorus Leaching from Soil Cores from a Twenty-Year Study Evaluating Alum Treatment of Poultry Litter.

11. The National Institute on Aging and the Alzheimer's Association Research Framework for Alzheimer's disease: Perspectives from the Research Roundtable.

12. Species interactions and the effects of climate variability on a wetland amphibian metacommunity.

13. Tau: From research to clinical development.

14. Neuropsychiatric symptoms as early manifestations of emergent dementia: Provisional diagnostic criteria for mild behavioral impairment.

15. Development of a patient-reported outcome instrument to assess complex activities of daily living and interpersonal functioning in persons with mild cognitive impairment: The qualitative research phase.

16. Assessing cognition and function in Alzheimer's disease clinical trials: Do we have the right tools?

17. Manchester Water Works Epitomizes Partnership Principles.

18. Neuropsychiatric symptoms in Alzheimer's disease: Past progress and anticipation of the future.

19. Revisiting the framework of the National Institute on Aging-Alzheimer's Association diagnostic criteria.

20. Experimental investigation of false positive errors in auditory species occurrence surveys.

22. Neuropsychiatric symptoms in Alzheimer’s disease.

23. Global issues in drug development for Alzheimer’s disease.

24. Scales as outcome measures for Alzheimer's disease.

25. Impact of protocol design on between scale discrepancies in early AD clinical trials.

26. Exploring discordant data in dementia clinical trials.

27. Near-Field Dust Exposure from Cotton Field Tilling and Harvesting.

28. Nutrient Input and Removal Trends for Agricultural Soils in Nine Geographic Regions in Arkansas.

29. An Index of Biological Integrity for Northern Mid-Atlantic Slope Drainages.

30. An Articulated Limb Motion Planner for Optimized Movement.

31. Exploring the causes of MMSE scoring and administration errors in the clinical trial screening period: Neuropsychiatry and behavioral neurology/treatment development and clinical trials.

32. The impact of protocol design on MMSE changes in the screening period: Human/Trial design.

39. THE MILD BEHAVIORAL IMPAIRMENT CHECKLIST (MBI-C): A NEW RATING SCALE FOR NEUROPSYCHIATRIC SYMPTOMS AS EARLY MANIFESTATIONS OF NEURODEGENERATIVE DISEASE.

46. Revising the administration of the ADAS-Cog.

Catalog

Books, media, physical & digital resources